Mardil Medical: Ventricular Reshaping To Treat Functional Mitral Regurgitation
Executive Summary
Mardil Medical Inc.’s VenTouch System for treating functional mitral valve regurgitation is intended to reshape and correct the geometry of the dilated heart, reduce or eliminate mitral valve regurgitation, and reduce heart wall stressors, all leading to a beneficial reverse remodeling effect.
You may also be interested in...
Warning Letter Roundup & Recap – 19 January 2021
No device-related warning letters were released by the US FDA the week of 19 January.
Start-Up Spotlight: CorWave Takes Inspiration From Nature To Tackle Heart Failure
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.
Immunocore Aims For $100m IPO After Immunotherapy Success
The UK biotech is set for a NASDAQ launch which could propel it to its first commercial launch by 2022.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: